These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22635680)

  • 1. Genomic characterization of human and rat prolactinomas.
    Tong Y; Zheng Y; Zhou J; Oyesiku NM; Koeffler HP; Melmed S
    Endocrinology; 2012 Aug; 153(8):3679-91. PubMed ID: 22635680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
    Cristina C; Díaz-Torga GS; Goya RG; Kakar SS; Perez-Millán MI; Passos VQ; Giannella-Neto D; Bronstein MD; Becu-Villalobos D
    Mol Cancer; 2007 Jan; 6():4. PubMed ID: 17222350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk.
    Paez-Pereda M; Giacomini D; Refojo D; Nagashima AC; Hopfner U; Grubler Y; Chervin A; Goldberg V; Goya R; Hentges ST; Low MJ; Holsboer F; Stalla GK; Arzt E
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1034-9. PubMed ID: 12552124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary prolactin-secreting tumor formation: recent developments.
    Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF
    Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA expression profile and differentially-expressed genes in prolactinomas following bromocriptine treatment.
    Wang C; Su Z; Sanai N; Xue X; Lu L; Chen Y; Wu J; Zheng W; Zhuge Q; Wu ZB
    Oncol Rep; 2012 May; 27(5):1312-20. PubMed ID: 22366961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of TGF-β/Smad signaling in dopamine agonist-resistant prolactinomas.
    Li Z; Liu Q; Li C; Zong X; Bai J; Wu Y; Lan X; Yu G; Zhang Y
    Mol Cell Endocrinol; 2015 Feb; 402():64-71. PubMed ID: 25578603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural and molecular history of prolactinoma: insights from a
    Bernard V; Villa C; Auguste A; Lamothe S; Guillou A; Martin A; Caburet S; Young J; Veitia RA; Binart N
    Oncotarget; 2018 Jan; 9(5):6144-6155. PubMed ID: 29464061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of silencing connexin43 on expression of pituitary tumor-transforming gene in prolactinomas.
    Wang H; Zhang Y; Zhou A; Zhang R; Meng Q
    Neurol Res; 2015 Feb; 37(2):153-8. PubMed ID: 25023895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Stem Cell Markers and Dopamine D2 Receptors in Human and Rat Prolactinomas.
    Gao Z; Cai L; Lu J; Wang C; Li Q; Chen J; Song X; Chen X; Zhang L; Zheng W; Su Z
    Med Sci Monit; 2017 Apr; 23():1827-1833. PubMed ID: 28411401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analyses.
    Evans CO; Moreno CS; Zhan X; McCabe MT; Vertino PM; Desiderio DM; Oyesiku NM
    Pituitary; 2008; 11(3):231-45. PubMed ID: 18183490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.
    Gao H; Wang F; Lan X; Li C; Feng J; Bai J; Cao L; Gui S; Hong L; Zhang Y
    BMC Cancer; 2015 Apr; 15():272. PubMed ID: 25884948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genes differentially expressed in prolactinomas responsive and resistant to dopamine agonists.
    Passos VQ; Fortes MA; Giannella-Neto D; Bronstein MD
    Neuroendocrinology; 2009; 89(2):163-70. PubMed ID: 18791324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between expression of vascular endothelial growth factor and the proliferation of prolactinomas.
    Li N; Jiang Z
    Clin Neurol Neurosurg; 2017 Feb; 153():102-106. PubMed ID: 28110235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophs.
    Peverelli E; Mantovani G; Vitali E; Elli FM; Olgiati L; Ferrero S; Laws ER; Della Mina P; Villa A; Beck-Peccoz P; Spada A; Lania AG
    J Clin Endocrinol Metab; 2012 Mar; 97(3):967-77. PubMed ID: 22259062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic SF3B1 hotspot mutation in prolactinomas.
    Li C; Xie W; Rosenblum JS; Zhou J; Guo J; Miao Y; Shen Y; Wang H; Gong L; Li M; Zhao S; Cheng S; Zhu H; Jiang T; Ling S; Wang F; Zhang H; Zhang M; Qu Y; Zhang Q; Li G; Wang J; Ma J; Zhuang Z; Zhang Y
    Nat Commun; 2020 May; 11(1):2506. PubMed ID: 32427851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary pituitary prolactinomas: a new rat model.
    Chedid A; Hoversland RC; Chejfec G; McCune SA; Jurin RR; Evans EE
    Acta Endocrinol (Copenh); 1988 Dec; 119(4):535-42. PubMed ID: 3059738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TGF-β1/Smad3-mediated fibrosis in drug resistance mechanism of prolactinoma.
    Hu B; Mao Z; Jiang X; He D; Wang Z; Wang X; Zhu Y; Wang H
    Brain Res; 2018 Nov; 1698():204-212. PubMed ID: 30055965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in the development of prolactinoma in mice overexpressing hCGβ: role of TGFβ1.
    Faraoni EY; Camilletti MA; Abeledo-Machado A; Ratner LD; De Fino F; Huhtaniemi I; Rulli SB; Díaz-Torga G
    J Endocrinol; 2017 Mar; 232(3):535-546. PubMed ID: 28096433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas.
    Cai L; Leng ZG; Guo YH; Lin SJ; Wu ZR; Su ZP; Lu JL; Wei LF; Zhuge QC; Jin K; Wu ZB
    Endocrine; 2016 Jun; 52(3):641-51. PubMed ID: 26662185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF-1 Gene Therapy as a Potentially Useful Therapy for Spontaneous Prolactinomas in Senile Rats.
    Brown OA; Canatelli-Mallat M; Console GM; Camihort G; Luna G; Spinedi E; Goya RG
    Curr Gene Ther; 2018; 18(4):240-245. PubMed ID: 30198429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.